AIG
ATNM icon

American International Group’s Actinium Pharmaceuticals ATNM Stock Holding History

American International Group’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,658
Closed -$107K – 239
2024
Q1 		$107K Buy
13,658
+92
+0.7% +$591 ﹤0.01% 2477
2023
Q4 		$68.9K Buy
13,566
+241
+2% +$1.24K ﹤0.01% 2730
2023
Q3 		$78.9K Buy
13,325
+805
+6% +$5.36K ﹤0.01% 2648
2023
Q2 		$92.9K Buy
+12,520
New +$107K ﹤0.01% 2627
2016
Q2 		– Sell
-70
Closed -$4K – 3141
2016
Q1 		$4K Hold
70
– – ﹤0.01% 4757
2015
Q4 		$7K Sell
70
-7
-9% -$465 ﹤0.01% 4614
2015
Q3 		$4K Buy
77
+40
+108% +$2.67K ﹤0.01% 4694
2015
Q2 		$2.92K Sell
37
-408
-92% -$34.8K ﹤0.01% 4846
2015
Q1 		$33K Hold
445
– – ﹤0.01% 4144
2014
Q4 		$78.6K Buy
445
+13
+3% +$2.47K ﹤0.01% 3749
2014
Q3 		$86.9K Hold
432
– – ﹤0.01% 3660
2014
Q2 		$93.5K Buy
+432
New +$144K ﹤0.01% 3638

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

American International Group's ATNM Position: Q2 2024 in Review

American International Group sold out of Actinium Pharmaceuticals (ATNM) in Q2 2024, closing a stake of 13,658 shares — an estimated $107K sold.

American International Group first reported a position in ATNM in Q2 2014 and held it in 12 quarters. The position peaked at $107K in Q1 2024. 74 funds tracked by Wall St. Rank hold ATNM as of Q2 2024.

  • American International Group reported no remaining Actinium Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 13,658 Actinium Pharmaceuticals shares in Q2 2024, an estimated $107K.
  • American International Group first reported a position in Actinium Pharmaceuticals in Q2 2014 and held it in 12 quarters.
  • American International Group's Actinium Pharmaceuticals position peaked at $107K in Q1 2024.
  • 74 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.